Pulmonx (NASDAQ: LUNG)
Pulmonx Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Pulmonx Company Info
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, and Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.
News & Analysis
Why Shares of Pulmonx Rose This Week
Thanks to sales of its Zephyr valve, the company's revenue is growing.
Why Pulmonx Stock Is Crashing Today
Investors are reacting negatively to the company's planned securities offering.
Valuation
Earnings Transcripts
Pulmonx Corporation (LUNG) Q2 2022 Earnings Call Transcript
LUNG earnings call for the period ending June 30, 2022.
Pulmonx Corporation (LUNG) Q1 2022 Earnings Call Transcript
LUNG earnings call for the period ending March 31, 2022.
Pulmonx Corporation (LUNG) Q4 2021 Earnings Call Transcript
LUNG earnings call for the period ending December 31, 2021.
Pulmonx Corporation (LUNG) Q3 2021 Earnings Call Transcript
LUNG earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.